vs
COMMUNITY TRUST BANCORP INC（CTBI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
COMMUNITY TRUST BANCORP INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$74.7M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 36.5%，领先347.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 13.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 12.8%）
社区信托银行集团是一家美国区域性银行控股公司，其前身是1903年成立的派克维尔国家银行，总部位于阿巴拉契亚地区核心的肯塔基州派克维尔。集团目前旗下经营商业银行社区信托银行，以及位于列克星敦的社区信托投资信托公司。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CTBI vs RIGL — 直观对比
营收规模更大
CTBI
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出7.4%
13.8%
净利率更高
RIGL
高出347.5%
36.5%
两年增速更快
RIGL
近两年复合增速
12.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $74.7M | $69.8M |
| 净利润 | $27.3M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 47.3% | 33.2% |
| 净利率 | 36.5% | 384.0% |
| 营收同比 | 13.8% | 21.2% |
| 净利润同比 | 21.3% | 1769.2% |
| 每股收益（稀释后） | $1.51 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTBIRIGL
| Q4 25 | $74.7M | $69.8M | ||
| Q3 25 | $71.5M | $69.5M | ||
| Q2 25 | $70.2M | $101.7M | ||
| Q1 25 | $66.2M | $53.3M | ||
| Q4 24 | $65.7M | $57.6M | ||
| Q3 24 | $62.8M | $55.3M | ||
| Q2 24 | $61.4M | $36.8M | ||
| Q1 24 | $58.7M | $29.5M |
净利润CTBIRIGL
| Q4 25 | $27.3M | $268.1M | ||
| Q3 25 | $23.9M | $27.9M | ||
| Q2 25 | $24.9M | $59.6M | ||
| Q1 25 | $22.0M | $11.4M | ||
| Q4 24 | $22.5M | $14.3M | ||
| Q3 24 | $22.1M | $12.4M | ||
| Q2 24 | $19.5M | $-1.0M | ||
| Q1 24 | $18.7M | $-8.2M |
毛利率CTBIRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率CTBIRIGL
| Q4 25 | 47.3% | 33.2% | ||
| Q3 25 | 43.2% | 40.9% | ||
| Q2 25 | 46.2% | 60.1% | ||
| Q1 25 | 42.9% | 23.9% | ||
| Q4 24 | 44.7% | 28.9% | ||
| Q3 24 | 43.8% | 25.4% | ||
| Q2 24 | 42.3% | 1.2% | ||
| Q1 24 | 40.6% | -23.6% |
净利率CTBIRIGL
| Q4 25 | 36.5% | 384.0% | ||
| Q3 25 | 33.4% | 40.2% | ||
| Q2 25 | 35.5% | 58.6% | ||
| Q1 25 | 33.2% | 21.5% | ||
| Q4 24 | 34.2% | 24.9% | ||
| Q3 24 | 35.3% | 22.5% | ||
| Q2 24 | 31.8% | -2.8% | ||
| Q1 24 | 31.8% | -27.9% |
每股收益（稀释后）CTBIRIGL
| Q4 25 | $1.51 | $14.11 | ||
| Q3 25 | $1.32 | $1.46 | ||
| Q2 25 | $1.38 | $3.28 | ||
| Q1 25 | $1.22 | $0.63 | ||
| Q4 24 | $1.25 | $0.82 | ||
| Q3 24 | $1.23 | $0.70 | ||
| Q2 24 | $1.09 | $-0.06 | ||
| Q1 24 | $1.04 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $363.7M | $155.0M |
| 总债务越低越好 | $63.8M | $52.5M |
| 股东权益账面价值 | $856.1M | $391.5M |
| 总资产 | $6.7B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CTBIRIGL
| Q4 25 | $363.7M | $155.0M | ||
| Q3 25 | $507.6M | $137.1M | ||
| Q2 25 | $395.3M | $108.4M | ||
| Q1 25 | $340.7M | $77.1M | ||
| Q4 24 | $369.5M | $77.3M | ||
| Q3 24 | $240.9M | $61.1M | ||
| Q2 24 | $161.7M | $49.1M | ||
| Q1 24 | $293.3M | $49.5M |
总债务CTBIRIGL
| Q4 25 | $63.8M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $64.0M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CTBIRIGL
| Q4 25 | $856.1M | $391.5M | ||
| Q3 25 | $831.4M | $117.6M | ||
| Q2 25 | $806.9M | $81.9M | ||
| Q1 25 | $784.2M | $18.6M | ||
| Q4 24 | $757.6M | $3.3M | ||
| Q3 24 | $760.8M | $-14.6M | ||
| Q2 24 | $719.3M | $-29.9M | ||
| Q1 24 | $707.7M | $-31.7M |
总资产CTBIRIGL
| Q4 25 | $6.7B | $513.6M | ||
| Q3 25 | $6.6B | $242.5M | ||
| Q2 25 | $6.4B | $206.7M | ||
| Q1 25 | $6.3B | $176.0M | ||
| Q4 24 | $6.2B | $164.0M | ||
| Q3 24 | $6.0B | $139.4M | ||
| Q2 24 | $5.8B | $128.4M | ||
| Q1 24 | $5.9B | $126.5M |
负债/权益比CTBIRIGL
| Q4 25 | 0.07× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.08× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $105.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $97.4M | — |
| 自由现金流率自由现金流/营收 | 130.3% | — |
| 资本支出强度资本支出/营收 | 10.2% | — |
| 现金转化率经营现金流/净利润 | 3.85× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $181.8M | — |
8季度趋势，按日历期对齐
经营现金流CTBIRIGL
| Q4 25 | $105.0M | $22.0M | ||
| Q3 25 | $37.5M | $24.0M | ||
| Q2 25 | $15.9M | $30.5M | ||
| Q1 25 | $36.6M | $-893.0K | ||
| Q4 24 | $105.3M | $14.5M | ||
| Q3 24 | $36.7M | $21.7M | ||
| Q2 24 | $20.0M | $302.0K | ||
| Q1 24 | $26.2M | $-5.0M |
自由现金流CTBIRIGL
| Q4 25 | $97.4M | — | ||
| Q3 25 | $36.4M | — | ||
| Q2 25 | $13.6M | — | ||
| Q1 25 | $34.5M | — | ||
| Q4 24 | $97.2M | — | ||
| Q3 24 | $35.4M | — | ||
| Q2 24 | $18.4M | — | ||
| Q1 24 | $24.0M | — |
自由现金流率CTBIRIGL
| Q4 25 | 130.3% | — | ||
| Q3 25 | 50.8% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 52.2% | — | ||
| Q4 24 | 148.0% | — | ||
| Q3 24 | 56.4% | — | ||
| Q2 24 | 30.1% | — | ||
| Q1 24 | 40.9% | — |
资本支出强度CTBIRIGL
| Q4 25 | 10.2% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 12.3% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 2.5% | — | ||
| Q1 24 | 3.7% | — |
现金转化率CTBIRIGL
| Q4 25 | 3.85× | 0.08× | ||
| Q3 25 | 1.57× | 0.86× | ||
| Q2 25 | 0.64× | 0.51× | ||
| Q1 25 | 1.66× | -0.08× | ||
| Q4 24 | 4.68× | 1.01× | ||
| Q3 24 | 1.66× | 1.75× | ||
| Q2 24 | 1.02× | — | ||
| Q1 24 | 1.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
